Capital Impact Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Capital Impact Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,247	Closed	-$1.91M	–	122
2018 Q4	$1.91M	Hold	14,247	–	–	0.82%	34
2018 Q3	$2.48M	Buy	14,247 +1,835	+15%	+$308K	0.85%	37
2018 Q2	$2.11M	Sell	12,412 -4,859	-28%	-$730K	0.78%	41
2018 Q1	$1.99M	Buy	+17,271	New	+$1.84M	0.82%	39

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Capital Impact Advisors's LOXO Position: Q1 2019 in Review

Capital Impact Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 14,247 shares — an estimated $1.91M sold.

Capital Impact Advisors first reported a position in LOXO in Q1 2018 and held it in 4 quarters. The position peaked at $2.48M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Capital Impact Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Capital Impact Advisors sold 14,247 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.91M.
Capital Impact Advisors first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 4 quarters.
Capital Impact Advisors's Loxo Oncology, Inc position peaked at $2.48M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Capital Impact Advisors's 13F filing for Q1 2019, filed 17 Apr 2019.